Crystalline Hemihydrate Solvent Selection for Pharmaceutical Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Obtaining a stable, pure, and crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate from organic solvents has been difficult, hindering its commercial use and pharmaceutical applications due to issues with handling qualities, filtration, and long-term stability.
Innovation Solution
The compound is crystallized from a water-containing solvent, resulting in a reproducible crystalline hemihydrate form with improved handling qualities and stability, characterized by specific X-ray powder diffraction and infra-red spectra, and can be produced through a process involving precipitation or recrystallization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If the compound is attempted to be crystallized from organic solvents, then the product should be obtained in crystalline form, but the crystallization is difficult and the product lacks good handling qualities
Solution Approach 1:
The patent changes the solvent system from organic solvents to water-containing solvents (aqueous systems). This parameter change in the crystallization medium enables the compound to form crystals with good handling qualities, including appropriate crystal habit, filterability, and drying characteristics that were not achievable with organic solvents.
Solution Approach 2:
The patent introduces water as an intermediary solvent to mediate the crystallization process. The water-containing solvent system acts as a mediator that facilitates the formation of a crystalline form with desirable properties, including improved filterability and drying characteristics, while maintaining the compound's pharmaceutical integrity.
2Manufacturing precision
If the product is to be produced in pure and crystalline form to meet pharmaceutical requirements, then the product quality is improved, but the manufacturing process becomes more difficult
Solution Approach 1:
The patent changes the crystallization parameters by using water-containing solvents instead of organic solvents. This parameter change simplifies the manufacturing process while simultaneously achieving the required product purity and crystallinity, as aqueous systems generally offer better safety profiles, easier handling, and more straightforward purification steps.
Solution Approach 2:
The patent employs water-containing solvents which are generally safer, more environmentally friendly, and easier to dispose of compared to organic solvents. This approach reduces the complexity of waste handling and regulatory compliance while maintaining high product purity standards, thereby simplifying the overall manufacturing process.
3Ease of operation
If the product should be readily filterable and easily dried, then the handling qualities are improved, but achieving this crystalline form from organic solvents has been difficult
Solution Approach 1:
The patent changes the solvent parameter to water-containing systems, which produce crystals with morphology and physical properties that are inherently more filterable and easier to dry. The aqueous crystallization process yields a crystalline form with characteristics that naturally enhance downstream processing efficiency without requiring complex process modifications.
4Stability of the object's composition
If the product should be stable for extended periods without specialized storage conditions, then the storage stability is improved, but obtaining the appropriate crystalline form has been difficult
Solution Approach 1:
The patent changes the crystallization solvent system to water-containing solvents, which produce a crystalline form with enhanced storage stability. The aqueous crystallization process yields a stable polymorph that maintains its composition and potency over extended periods under normal storage conditions, eliminating the need for specialized storage while simplifying the overall process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystalline form is more stable, easier to isolate, and exhibits excellent blood glucose lowering effects, making it suitable for treating various diabetic and metabolic disorders, with enhanced pharmaceutical properties and extended storage capabilities.
Implementation Method 1
the compound of formula (I) hemihydrate can be produced in a crystalline form
Implementation Method 2
crystalline form of hemihydrate of the compound of formula (I)
Data Source
Figure 1
Figure 2
AI summary
A novel crystal form of 1- (ß-D-glucopyranosyl) -4-methyl-3- [5- (4-f luorophenyl) -2-thienylmethyl] benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra¬ red spectrum.